Newsstand Menu

CRISPR-based system highlights new drug targets in a deadly leukemia

Scientists have harnessed CRISPR, the gene-editing tool, to find highly specific dependencies in a deadly subtype of leukemia. They used an experimental drug to target these, halting cancer growth in cultured cells.

More Videos